Rudi A J O Dierckx Selected Research

rimcazole

9/2013	In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imaging.
11/2010	Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rudi A J O Dierckx Research Topics

Disease

33	Neoplasms (Cancer) 03/2022 - 01/2008
13	Neuroinflammatory Diseases 01/2022 - 10/2014
11	Inflammation (Inflammations) 11/2021 - 06/2010
7	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2014
6	Multiple Sclerosis 01/2022 - 02/2014
5	Glioma (Gliomas) 03/2022 - 04/2013
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2016
5	Infections 05/2021 - 01/2013
4	Mycoses (Diseases, Fungus) 11/2021 - 01/2016
4	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2010
4	Atherosclerotic Plaque (Atheroma) 12/2015 - 12/2010
4	Demyelinating Diseases (Demyelinating Disease) 10/2014 - 02/2014
3	Melanoma (Melanoma, Malignant) 03/2022 - 11/2010
3	Carcinoma (Carcinomatosis) 03/2022 - 11/2012
3	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2016
3	Brain Diseases (Brain Disorder) 12/2021 - 03/2014
3	Cognitive Dysfunction 01/2021 - 04/2015
3	Atherosclerosis 12/2015 - 12/2010
3	Thyroid Neoplasms (Thyroid Cancer) 08/2014 - 01/2008
3	Neoplasm Metastasis (Metastasis) 08/2014 - 05/2010
3	Amyloidosis 03/2014 - 10/2012
2	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 01/2022
2	Body Weight (Weight, Body) 03/2021 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2020 - 04/2013
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 08/2014
2	Disease Progression 01/2017 - 08/2014
2	Pneumonia (Pneumonitis) 10/2015 - 01/2013
2	Mental Disorders (Mental Disorder) 06/2015 - 08/2014
2	Sleep Deprivation 06/2015 - 04/2015
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015 - 09/2008
1	Dopa-responsive Dystonia 01/2022
1	Neurobehavioral Manifestations 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Sepsis (Septicemia) 01/2021

Drug/Important Bio-Agent (IBA)

11	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2013
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 02/2009
7	RadiopharmaceuticalsIBA 01/2021 - 01/2010
7	LigandsIBA 08/2016 - 01/2010
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2010
4	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 03/2011
4	Radioisotopes (Radionuclides)IBA 11/2021 - 01/2011
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 07/2013
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2017 - 06/2013
3	Methionine (L-Methionine)FDA Link 02/2022 - 01/2018
3	N-methyl-4,4'-diaminostilbeneIBA 01/2022 - 02/2014
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 01/2010
3	fluorodopa F 18IBA 01/2020 - 10/2009
3	Dihydroxyphenylalanine (Dopa)IBA 01/2020 - 10/2009
3	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2020 - 10/2016
3	Deoxyglucose (2 Deoxy D glucose)IBA 07/2019 - 02/2012
3	Biological ProductsIBA 05/2019 - 12/2010
3	Estrogen ReceptorsIBA 11/2017 - 11/2016
3	Estrogens (Estrogen)FDA Link 04/2017 - 03/2014
3	Matrix Metalloproteinases (MMPs)IBA 10/2015 - 01/2013
2	AntibodiesIBA 03/2022 - 01/2008
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 09/2015
2	EnzymesIBA 11/2021 - 11/2012
2	Monoclonal AntibodiesIBA 05/2021 - 01/2018
2	Antimicrobial PeptidesIBA 05/2021 - 01/2013
2	Cholinergic Agents (Cholinergics)IBA 01/2021 - 01/2020
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2020 - 05/2019
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2019 - 05/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2018 - 01/2013
2	Estradiol (Delestrogen)FDA LinkGeneric 11/2017 - 04/2017
2	2- fluoro- 6- (6- hydroxynaphthalen- 2- yl)pyridin- 3- olIBA 11/2017 - 04/2017
2	GenisteinIBA 11/2017 - 04/2017
2	salicylhydroxamic acid (SHAM)IBA 10/2016 - 01/2015
2	sigma Receptors (sigma Receptor)IBA 10/2015 - 01/2010
2	Antineoplastic Agents (Antineoplastics)IBA 10/2015 - 01/2010
2	SA 4503IBA 06/2015 - 04/2015
2	Sigma-1 ReceptorIBA 06/2015 - 04/2015
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 10/2014 - 05/2014
2	rimcazoleIBA 09/2013 - 11/2010
2	BombesinIBA 02/2013 - 01/2013
2	Bombesin Receptors (Bombesin Receptor)IBA 02/2013 - 01/2013
2	Insulin (Novolin)FDA Link 12/2012 - 11/2012
2	CatecholaminesIBA 10/2011 - 10/2009
1	Epithelial Cell Adhesion MoleculeIBA 03/2022
1	IsotopesIBA 03/2022
1	AntigensIBA 03/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 03/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2022
1	Histamine AgonistsIBA 01/2022
1	6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA 01/2022
1	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 01/2022
1	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2022
1	Cyclooxygenase 1IBA 11/2021
1	IronIBA 05/2021
1	enzalutamideIBA 01/2021
1	Anesthetics (Anesthetic Agents)IBA 01/2021

Therapy/Procedure

14	Therapeutics 01/2021 - 01/2010
6	Radiotherapy 03/2022 - 01/2011
3	Immunotherapy 01/2018 - 11/2010
2	Aftercare (After-Treatment) 01/2017 - 05/2010
1	Transplantation 04/2021
1	Conscious Sedation 01/2021